MedTrace Logo

Covid-19 Long-term Revalidation Follow-up

NCT04685629 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-05-09

No results posted yet for this study

Summary

In this monocentric, prospective and descriptive trial we want to evaluate the long-term consequences for patients treated for Covid-19. Covid patients who were hospitalized for min. 5 days either in a Covid-19 department or in intensive care unit will be followed-up for 8 weeks after hospital discharge. This is done via an innovative electronic platform in the home environment (UZA@home). On the one hand the quality of life, rehabilitation and reintegration of the patient will be evaluated and on the other hand the patient will be screened for various psychosocial aspects such as anxiety, depression and post-traumatic stress syndrome.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

25 post ICU-patients

patients who were hospitalized in an intensive care unit

OTHER

25 post non-ICU patients

patients who were not hospitalized in an intensive care unit

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-07
Primary Completion
2022-05-22
Completion
2022-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04685629 on ClinicalTrials.gov